Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

477
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
477
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

604
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
604
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

756
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
756
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

800
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
800
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

331
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
331

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating toolkits for inclusivity, diversity, equity, and accessibility in clinical trials: a scoping review protocol.

Frontiers in public health·2026
Same author

Utility of genetic screening for the prediction of severe arrhythmic outcomes in mitral valve prolapse.

medRxiv : the preprint server for health sciences·2026
Same author

Sex differences in reverse remodeling after transcatheter aortic valve replacement in low-flow aortic stenosis.

The Journal of invasive cardiology·2026
Same author

Leveraging Self-Reporting in an Existing e-Cohort to Identify Clinically Relevant Mitral Valve Prolapse: Pilot Questionnaire Study.

JMIR formative research·2026
Same author

Factors Associated with Aortic Valve Calcification in Type 2 Diabetes - A Steno INTEN-CT substudy.

European heart journal. Cardiovascular Imaging·2026
Same author

Prevalence, Genetics, and Imaging Characteristics of Patients with Mitral Valve Prolapse and Arrhythmogenic Right Ventricular Cardiomyopathy.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Feb 18, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

5.6K

Cardiac remodelling in aortic stenosis.

Marie-Annick Clavel1, Lionel Tastet1, Philippe Pibarot1

  • 1Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.

Archives of Cardiovascular Diseases
|February 16, 2026
PubMed
Summary

Aortic stenosis (AS) causes heart muscle damage. Early intervention with valve replacement and new imaging biomarkers can prevent irreversible damage and heart failure.

Keywords:
Aortic stenosisAortic valve replacementEchocardiographyLeft ventricular remodellingMyocardial fibrosis

More Related Videos

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.7K
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.7K

Related Experiment Videos

Last Updated: Feb 18, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

5.6K
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.7K
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.7K

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac Pathophysiology

Background:

  • Aortic stenosis (AS) causes progressive left ventricular pressure overload.
  • Myocardial response initially preserves function but becomes maladaptive, leading to fibrosis and heart failure.
  • Current guidelines for valve replacement may not prevent irreversible myocardial damage.

Purpose of the Study:

  • To explore integrating myocardial fibrosis assessment into clinical decision-making for severe AS.
  • To identify patients with asymptomatic severe AS who benefit from earlier intervention.
  • To review advances in imaging biomarkers for risk stratification in AS.

Main Methods:

  • Review of current literature on aortic stenosis pathophysiology and management.
  • Analysis of advanced imaging biomarkers: cardiac MRI (late gadolinium enhancement, extracellular volume, strain analysis).
  • Discussion of adjunctive pharmacological strategies and management of comorbidities.

Main Results:

  • Myocardial fibrosis assessment can aid in staging AS and guiding earlier valve replacement.
  • Advanced imaging biomarkers enable personalized risk stratification for asymptomatic severe AS.
  • Adjunctive therapies and comorbidity management are crucial for optimal outcomes post-valve replacement.

Conclusions:

  • Integrating fibrosis assessment and advanced imaging can personalize AS management.
  • Earlier intervention in severe AS may prevent irreversible myocardial damage.
  • Comprehensive management including pharmacotherapy and comorbidity control is essential.